Kishida Yuki, Kagawa Syota, Arimitsu Junsuke, Nakanishi Miho, Sakashita Noriko, Otsuka Shizue, Yoshikawa Hideki, Hagihara Keisuke
Department of Kampo Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Orthopaedics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Phytomedicine. 2015 Jan 15;22(1):16-22. doi: 10.1016/j.phymed.2014.11.005. Epub 2014 Nov 20.
Sarcopenia is characterized by age-associated skeletal muscle atrophy and reduced muscle strength; currently, no pharmaceutical treatment is available. Go-sha-jinki-Gan (GJG) is a traditional Japanese herbal medicine that is used to alleviate various age-related symptoms, especially motor disorders. Here, we investigated the effect of GJG on aging-associated skeletal muscle atrophy by using senescence-accelerated mice (SAMP8). Immunohistochemical and western blotting analyses clearly showed that GJG significantly reduced the loss of skeletal muscle mass and ameliorated the increase in slow skeletal muscle fibers in SAMP8 mice compared to control mice. The expression levels of Akt and GSK-3β, the phosphorylation of FoxO4, and the phosphorylations of AMPK and mitochondrial-related transcription factors such as PGC-1α were suppressed, while the expression of MuRF1 increased in SAMP8 mice, but approximated that in senescence-accelerated aging-resistant (SAMR1) mice after GJG treatment. We demonstrate for the first time that GJG has a therapeutic effect against sarcopenia.
肌肉减少症的特征是与年龄相关的骨骼肌萎缩和肌肉力量下降;目前尚无药物治疗方法。五社参杞汤(GJG)是一种传统的日本草药,用于缓解各种与年龄相关的症状,尤其是运动障碍。在此,我们通过使用衰老加速小鼠(SAMP8)研究了GJG对衰老相关骨骼肌萎缩的影响。免疫组织化学和蛋白质印迹分析清楚地表明,与对照小鼠相比,GJG显著减少了SAMP8小鼠骨骼肌质量的损失,并改善了慢肌纤维的增加。在SAMP8小鼠中,Akt和GSK-3β的表达水平、FoxO4的磷酸化以及AMPK和线粒体相关转录因子(如PGC-1α)的磷酸化受到抑制,而MuRF1的表达增加,但在GJG治疗后接近衰老加速抗老化(SAMR1)小鼠中的表达。我们首次证明GJG对肌肉减少症具有治疗作用。